Open Access
Endoscopic transvesical adenomectomy of the prostate, a new minimal invasive approach for large benign prostatic hyperplasia. What has our experience taught us?
Author(s) -
Luís Vale,
L. Fossion
Publication year - 2020
Publication title -
central european journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.403
H-Index - 20
eISSN - 2080-4873
pISSN - 2080-4806
DOI - 10.5173/ceju.2020.0053.r3
Subject(s) - medicine , perioperative , blood loss , prostate , hyperplasia , international prostate symptom score , urology , surgery , lower urinary tract symptoms , cancer
Recent technical advances have made new minimally invasive techniques possible to treat large volume (>80 ml) benign prostatic hyperplasia (BPH). The endoscopic transperitoneal adenomectomy of the prostate (ETAP) is a new minimally invasive technique developed in our centre. The aim of this study was to describe the safety, efficacy and to evaluate our learning curve in ETAP.